HQL
abrdn Life Sciences Investors
HQL
HQL
59 hedge funds and large institutions have $60.2M invested in abrdn Life Sciences Investors in 2018 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 16 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
1% less capital invested
Capital invested by funds: $61M → $60.2M (-$713K)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
59
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.05M | |
| 2 | +$668K | |
| 3 | +$550K | |
| 4 |
NMC
Nine Masts Capital
Central,
Hong Kong
|
+$456K |
| 5 |
DA
Doliver Advisors
Houston,
Texas
|
+$357K |
Top Sellers
| 1 | -$2.64M | |
| 2 | -$582K | |
| 3 | -$192K | |
| 4 |
LPL Financial
San Diego,
California
|
-$158K |
| 5 |
AG
Advisor Group
Phoenix,
Arizona
|
-$128K |